Signet Ring Cell Variant of ILC of Breast
Breast cancer is the most common type of cancer diagnosed in women. It is a type of cancer in which certain cells in the breast become abnormal, grow uncontrollably, and form a malignant mass (tumor). There are various types of breast cancers which include ductal carcinoma and lobular carcinoma.
The topic Signet Ring Cell Variant of ILC of Breast you are seeking is a synonym, or alternative name, or is closely related to the medical condition Signet Ring Cell Carcinoma of Breast.
- Breast cancer is the most common type of cancer diagnosed in women. It is a type of cancer in which certain cells in the breast become abnormal, grow uncontrollably, and form a malignant mass (tumor). There are various types of breast cancers which include ductal carcinoma and lobular carcinoma
- Signet Ring Cell Carcinoma (SRCC) of Breast is a rare mucinous type of carcinoma of breast. It is observed as a soft mass in the breast, in women around the age of 40 years. Two types of Signet Ring Cell Carcinomas are observed: One is lobular carcinoma type and the other is similar to diffuse gastric carcinoma
- Numerous studies have shown that Signet Ring Cell Carcinoma of Breast can either be a variant of invasive lobular carcinoma (ILC) or a variant of invasive ductal carcinoma (IDC). According to many experts, Mammary Signet Ring Cell Carcinoma is considered to be a unique subtype of breast cancer
- The signs and symptoms of Signet Ring Cell Carcinoma of Breast include the presence of a lump in the breast, swelling or skin thickening around the region of the lump, and change in breast profile
- Complications from this cancer type includes the spread of cancer from the breast to other locations and treatment side effects that may include nausea, vomiting, and hair loss
- In order to treat Signet Ring Cell Carcinoma of Breast, the healthcare provider may use a combination of therapies that may include surgery, chemotherapy, radiation therapy and targeted therapy, depending on the stage of the tumor
- Specific information on prognosis of Signet Ring Cell Carcinoma of Breast is not available, due to it being a very rare condition. Some studies have shown that the prognosis may be similar to other types of breast cancer, and depends on the stage of the tumor, grade of the tumor, age of the individual, and response to treatment, among many other factors
Please find comprehensive information on Signet Ring Cell Carcinoma of Breast regarding definition, distribution, risk factors, causes, signs & symptoms, diagnosis, complications, treatment, prevention, prognosis, and additional useful information HERE.
What are some Useful Resources for Additional Information?
Breast Cancer Education Association
1027 W. Roselawn Avenue, Roseville, MN 55113
Phone: (651) 487-3578
American Cancer Society (ACS)
1599 Clifton Road, NE Atlanta, GA 30329-4251
Toll-Free: (800) 227-2345
TTY: (866) 228-4327
National Cancer Institute (NCI)
U.S. National Institutes of Health
Public Inquiries Office
Building 31, Room 10A03
31 Center Drive, MSC 8322 Bethesda, MD 20892-2580
Phone: (301) 435-3848
Toll-Free: (800) 422-6237
TTY: (800) 332-8615
References and Information Sources used for the Article:
Lakhani, S. R. (Ed.). (2012). WHO classification of tumours of the breast. International Agency for Research on Cancer.
http://womenshealth.gov/breast-cancer/what-is-breast-cancer/index.html (accessed on 06/20/16)
http://www.cdc.gov/cancer/breast/basic_info/index.htm (accessed on 06/20/16)
http://www.mayoclinic.com/health/breast-cancer/DS00328 (accessed on 06/20/16)
http://radiopaedia.org/articles/primary-osteosarcoma-of-the-breast (accessed on 06/20/16)
http://www.archivesofpathology.org/doi/pdf/10.1043/1543-2165(2007)131%5B792%3APOOTBR%5D2.0.CO%3B2 (accessed on 06/20/16)
Helpful Peer-Reviewed Medical Articles:
Lafleur, E. A., Jia, S. F., Worth, L. L., Zhou, Z., Owen-Schaub, L. B., & Kleinerman, E. S. (2001). Interleukin (IL)-12 and IL-12 gene transfer up-regulate Fas expression in human osteosarcoma and breast cancer cells. Cancer research, 61(10), 4066-4071.
Sabaté, J. M., Gómez, A., Torrubia, S., & Flotats, A. (2002). Osteosarcoma of the breast. American Journal of Roentgenology, 179(1), 277-278.
Skálová, A., Vanecek, T., Sima, R., Laco, J., Weinreb, I., Perez-Ordonez, B., ... & Ryska, A. (2010). Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. The American journal of surgical pathology, 34(5), 599-608.
Chiosea, S. I., Griffith, C., Assaad, A., & Seethala, R. R. (2012). The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma. The American journal of surgical pathology, 36(3), 343-350.
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., ... & Bigner, S. H. (1997). PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. science, 275(5308), 1943-1947.
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., ... & Simeone, D. M. (2007). Identification of pancreatic cancer stem cells. Cancer research, 67(3), 1030-1037.